论文部分内容阅读
目的:采用国际生存质量量表评价中医辨证论治提高老年晚期非小细胞肺癌(NSCLC)同步放化疗的耐受性。方法:将20例Ⅲ-Ⅳ期老年NSCLC患者随机分为两组,研究组(10例)接受中医辨证论治及同步放化疗,对照组(10例)仅进行同步放化疗,共观察两个疗程。采用EORTC QLQ-C30、KPS、ECOG作为测定工具。结果:研究组生存质量各领域评分治疗后改善明显,对照组则下降,两组间比较差异有显著性(P<0.05);KPS、ECOG评分显示相似结果。结论:老年晚期非小细胞肺癌同步放化疗配合中医辨证论治能够改善患者生存质量,改善体能状态。
OBJECTIVE: To evaluate the treatment of advanced non-small cell lung cancer (NSCLC) with concurrent chemoradiation by using the International Quality of Life Scale. Methods: Twenty patients with stage Ⅲ-Ⅳ NSCLC were randomly divided into two groups. The study group (10 cases) received TCM syndrome differentiation and concurrent chemoradiotherapy. The control group (10 cases) received concurrent chemoradiotherapy only for two courses. Using EORTC QLQ-C30, KPS, ECOG as a measurement tool. Results: The quality of life of the study group improved significantly in all fields after treatment, but decreased in the control group, with significant difference between the two groups (P <0.05). KPS and ECOG scores showed similar results. Conclusions: Concurrent radiotherapy and chemotherapy with senile advanced non-small cell lung cancer can improve the quality of life and improve the physical fitness of patients with TCM syndrome differentiation.